Title

Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancers

Document Type

Article

Publication Date

June 2020

Publication Title

bioRxiv

DOI

10.1101/2020.06.07.136366

Share

COinS